Search

Search Results

1. Multiple myeloma

   Multiple myeloma (MM) is a haematological lymphoid malignancy involving tumoural plasma cells and is usually characterized by the presence of a...

   Florent Malard, Paola Neri, ... Mohamad Mohty in Nature Reviews Disease Primers

   Article 27 June 2024
   

2. Personalized Treatment of Multiple Myeloma in Frail Patients

   Purpose of Review

   As the treatment landscape for multiple myeloma (MM) continues to expand at a rapid pace, management of older adults and frail...

   Jodi J. Lipof, Nadine Abdallah, Brea Lipe in Current Oncology Reports

   Article 18 May 2024

3. Assessment tools for patient-reported outcomes in multiple myeloma

   Background

   Patients with multiple myeloma experience severe symptom burden. Patient participation in self-reporting is essential as medical staff’s...

   Ting Wang, Qin Lu, LeiWen Tang in Supportive Care in Cancer

   Article Open access 30 June 2023

4. Potential Clinical Role of LncRNA miR503HG in Multiple Myeloma and its Effect on the Proliferation and Adhesion of Myeloma Cells

   This study mainly explored the role of lncRNA miR503HG in multiple myeloma and the potential downstream regulatory mechanism affecting disease....

   **ling Yin, **ang Zhou in Indian Journal of Hematology and Blood Transfusion

   Article 21 April 2023
   

5. ASH highlights 2022—multiple myeloma

   The 64th annual meeting was held in New Orleans, Louisiana from December 10–13, 2022. More than 150 abstracts concerning multiple myeloma have been...

   Lina Z. Rüsing, Hermine Agis, Maria Krauth in memo - Magazine of European Medical Oncology

   Article Open access 22 July 2023

6. Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth

   The hypercoagulable state is a hallmark for patients with multiple myeloma (MM) and is associated with disease progression. Activated platelets...

   Meng Gao, Hang Dong, ... Yanwei Luo in Oncogenesis

   Article Open access 13 June 2024
   

7. Bispecific antibodies for multiple myeloma: past, present and future

   Despite the development of various therapeutic agents, multiple myeloma remains incurable. Recently, T-cell redirected immunotherapy has become a...

   Toshiki Ochi, Tatsuya Konishi, Katsuto Takenaka in International Journal of Hematology

   Article 13 April 2024
   

8. The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma

   Maintenance therapies in multiple myeloma improve survival after induction treatment. This study characterizes the strategies for maintenance therapy...

   Syed Maaz Tariq, Al-Ola Abdallah, ... Alec Britt in Clinical Hematology International

   Article Open access 03 May 2023
   

9. Immune checkpoint inhibitors for multiple myeloma immunotherapy

   Multiple myeloma (MM) is related to immune disorders, recent studys have revealed that immunotherapy can greatly benefit MM patients. Immune...

   Zhaoyun Liu, **ntong Xu, ... Rong Fu in Experimental Hematology & Oncology

   Article Open access 28 November 2023
   

10. How should multiple myeloma research change in a patient-oriented world? Findings and lessons from the pan-Canadian myeloma priority setting partnership

    Background

    Over the last decade there has been considerable research into the treatment, management, and quality of life of people living with...

    Sarah Bridges, Samantha Fowler, ... Anthony Reiman in Research Involvement and Engagement

    Article Open access 29 July 2023
    

11. Update on kidney injury caused by multiple myeloma

    Multiple myeloma (MM) is a form of clonal plasma cell malignancy that associates with clinical manifestations such as anemia, hypercalcemia, bone...

    Linhui Wang, Chen Liu, ... Yiyao Deng in Annals of Hematology

    Article 28 June 2024
    

12. Detection of myeloma cell-derived microvesicles: a tool to monitor multiple myeloma load

    The persistence of tumor load in multiple myeloma (MM) lead to relapse in patients achieving complete remission (CR). Appropriate and effective...

    Zhao-Yun Liu, Nan-Hao Meng, ... Rong Fu in Experimental Hematology & Oncology

    Article Open access 06 March 2023
    

13. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines

    Venous thromboembolism (VTE) poses a significant challenge in the context of multiple myeloma, with an incidence of up to 10% in newly diagnosed...

    Charalampos Charalampous, Darshi Shah, ... Rajshekhar Chakraborty in Annals of Hematology

    Article 17 April 2024

14. Correlation Between Bariatric Surgery and the Risk of Multiple Myeloma: Results from an Evidence-Based Strategy

    Objective

    We conducted a meta-analysis of current literature to assess whether bariatric surgery(BS) has a positive effect on reducing the risk of...

    Qiong Wu, Tiantian Zhao, ... Mingxu Da in Obesity Surgery

    Article 17 January 2024
    

15. Severe hypoglycemia due to insulin auto-antibodies of newly diagnosed multiple myeloma: A case report

    Objective

    Insulin autoimmune syndrome (IAS) is a rare condition that can be overlooked in the differential diagnosis of hypoglycemia. Hematologic...

    Sedat Can Guney, Mine Miskioglu, ... Zeliha Hekimsoy in International Journal of Diabetes in Develo** Countries

    Article 13 October 2023
    

16. An MRI-based radiomics nomogram for differentiating spinal metastases from multiple myeloma

    Background

    Spinal metastasis and multiple myeloma share many overlap** conventional radiographic imaging characteristics, thus, their...

    Shuai Zhang, Menghan Liu, ... **ming Wang in Cancer Imaging

    Article Open access 24 July 2023
    

17. Occurrence of Monoclonal Band in Alpha Region on Serum Electrophoresis in Multiple Myeloma: A Diagnostic Conundrum

    The presence of an M-band in serum and/or urine electrophoresis is a crucial diagnostic indicator for multiple myeloma and other plasma cell...

    Nisha Duggal, Mahendra Kumar, ... Ritu Aggarwal in Indian Journal of Hematology and Blood Transfusion

    Article 24 May 2024
    

18. Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast

    Immunotherapies have significantly improved outcomes in patients with multiple myeloma yet maintaining a durable response in heavily pretreated...

    Luciano J. Costa, Paula Rodriguez-Otero in Advances in Therapy

    Article Open access 20 April 2024

19. The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis

    Background

    During chemotherapy for multiple myeloma, symptoms include those related to the disease, as well as adverse effects of the treatment. Few...

    Lihong Zeng, Hui Huang, ... Jiandang Zhou in Supportive Care in Cancer

    Article 25 April 2023
    

20. Myosteatosis in multiple myeloma: a key determinant of survival beyond sarcopenia

    Objective

    Fatty infiltration of skeletal muscle (Myosteatosis) is associated with increased frailty, decreased muscle and mobility function, which...

    Thierno D. Diallo, Ariane Irma Luise Blessing, ... Jakob Neubauer in Skeletal Radiology

    Article Open access 28 June 2024